Literature DB >> 22018418

Influenza.

Eliana Ferroni1, Tom Jefferson.   

Abstract

INTRODUCTION: During the autumn-winter months (influenza seasons), influenza circulates more frequently, causing a greater proportion of influenza-like illness and sometimes serious seasonal epidemics. The incidence of symptoms related to influenza as well as influenza-like illness depends on the underlying immunity of the population. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical question: What are the effects of vaccines to prevent influenza? We searched: Medline, Embase, The Cochrane Library, and other important databases up to March 2011 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 9 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: vaccines in adults, children, and older people.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22018418      PMCID: PMC3217790     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  23 in total

1.  Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Carolyn B Bridges; Keiji Fukuda; Timothy M Uyeki; Nancy J Cox; James A Singleton
Journal:  MMWR Recomm Rep       Date:  2002-04-12

Review 2.  Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials.

Authors:  Nicola J Cooper; Alexander J Sutton; Keith R Abrams; Allan Wailoo; David Turner; Karl G Nicholson
Journal:  BMJ       Date:  2003-06-07

Review 3.  Influenza.

Authors:  N J Cox; K Fukuda
Journal:  Infect Dis Clin North Am       Date:  1998-03       Impact factor: 5.982

Review 4.  Does this patient have influenza?

Authors:  Stephanie A Call; Mark A Vollenweider; Carlton A Hornung; David L Simel; W Paul McKinney
Journal:  JAMA       Date:  2005-02-23       Impact factor: 56.272

5.  Guideline for prevention of nosocomial pneumonia. The Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention.

Authors:  O C Tablan; L J Anderson; N H Arden; R F Breiman; J C Butler; M M McNeil
Journal:  Infect Control Hosp Epidemiol       Date:  1994-09       Impact factor: 3.254

Review 6.  Antivirals for influenza in healthy adults: systematic review.

Authors:  T Jefferson; V Demicheli; D Rivetti; M Jones; C Di Pietrantonj; A Rivetti
Journal:  Lancet       Date:  2006-01-28       Impact factor: 79.321

7.  Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study.

Authors:  M C Zambon; J D Stockton; J P Clewley; D M Fleming
Journal:  Lancet       Date:  2001-10-27       Impact factor: 79.321

8.  Influenzavirus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness.

Authors:  J P Fox; M K Cooney; C E Hall; H M Foy
Journal:  Am J Epidemiol       Date:  1982-08       Impact factor: 4.897

9.  Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden.

Authors:  K G Nicholson; J Kent; V Hammersley; E Cancio
Journal:  BMJ       Date:  1997-10-25

10.  Viruses and bacteria in the etiology of the common cold.

Authors:  M J Mäkelä; T Puhakka; O Ruuskanen; M Leinonen; P Saikku; M Kimpimäki; S Blomqvist; T Hyypiä; P Arstila
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.